Literature DB >> 2537466

Class I cross-restricted T cells reveal low responder allele due to processing of viral antigen.

H C Bodmer1, F M Gotch, A J McMichael.   

Abstract

Cytotoxic T lymphocytes (CTL) recognize protein antigens which have been processed by the target cell and then presented in association with the relevant class I molecule of the major histocompatibility complex (MHC). Short synthetic peptides, which are able to associate directly with target cells, may substitute for these processed fragments in stimulating antigen-specific CTL responses. Using this approach, a dominant HLA-A2-restricted epitope has previously been mapped to residues 58-68 of influenza A virus matrix protein. Here we report HLA-A2-restricted CTL which are also able to recognize this short synthetic peptide in association with HLA-Aw69, but which fail to recognize HLA-Aw69 expressing cells infected with influenza A virus. Furthermore, individuals possessing HLA-Aw69 who respond to influenza A virus, do not respond to M58-68. These results imply that the low response to this epitope on infection of HLA-Aw69 individuals with influenza A is due to failure of the naturally processed product of matrix protein to associate with Aw69.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2537466     DOI: 10.1038/337653a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  14 in total

1.  Protection against lethal cytomegalovirus infection by a recombinant vaccine containing a single nonameric T-cell epitope.

Authors:  M Del Val; H J Schlicht; H Volkmer; M Messerle; M J Reddehase; U H Koszinowski
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

2.  Dissection of H-2Db-restricted cytotoxic T-lymphocyte epitopes on simian virus 40 T antigen by the use of synthetic peptides and H-2Dbm mutants.

Authors:  S S Tevethia; M Lewis; Y Tanaka; J Milici; B Knowles; W L Maloy; R Anderson
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

3.  Specific cytotoxic T lymphocytes recognize the immediate-early transactivator Zta of Epstein-Barr virus.

Authors:  C Bogedain; H Wolf; S Modrow; G Stuber; W Jilg
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

4.  An epitope in human immunodeficiency virus 1 reverse transcriptase recognized by both mouse and human cytotoxic T lymphocytes.

Authors:  A Hosmalin; M Clerici; R Houghten; C D Pendleton; C Flexner; D R Lucey; B Moss; R N Germain; G M Shearer; J A Berzofsky
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

5.  HLA-associated susceptibility to HIV-1 infection.

Authors:  G Fabio; R Scorza; A Lazzarin; M Marchini; M Zarantonello; A D'Arminio; P Marchisio; A Plebani; R Luzzati; P Costigliola
Journal:  Clin Exp Immunol       Date:  1992-01       Impact factor: 4.330

6.  Identification of multirestricted immunodominant regions recognized by cytolytic T lymphocytes in the human immunodeficiency virus type 1 Nef protein.

Authors:  B Culmann-Penciolelli; S Lamhamedi-Cherradi; I Couillin; N Guegan; J P Levy; J G Guillet; E Gomard
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

7.  Defects in antigen presentation of mutant influenza haemagglutinins are reversed by mutations in the MHC class II molecule.

Authors:  A P Warren; I Paschedag; C Benoist; J Peccoud; D Mathis; D B Thomas
Journal:  EMBO J       Date:  1990-12       Impact factor: 11.598

8.  HLA-A2 subtypes are functionally distinct in peptide binding and presentation.

Authors:  D Barouch; T Friede; S Stevanović; L Tussey; K Smith; S Rowland-Jones; V Braud; A McMichael; H G Rammensee
Journal:  J Exp Med       Date:  1995-12-01       Impact factor: 14.307

9.  Translocation of peptides through microsomal membranes is a rapid process and promotes assembly of HLA-B27 heavy chain and beta 2-microglobulin translated in vitro.

Authors:  F Lévy; R Larsson; S Kvist
Journal:  J Cell Biol       Date:  1991-11       Impact factor: 10.539

10.  Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes.

Authors:  P Panina-Bordignon; R Lang; P M van Endert; E Benazzi; A M Felix; R M Pastore; G A Spinas; F Sinigaglia
Journal:  J Exp Med       Date:  1995-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.